Scientists used next-generation sequencing to explore endogenous miRNAs in chronic myeloid leukemia (CML) patients versus healthy volunteers, and miR-342-5p was identified as the primary target. They found that miR-342-5p was downregulated in CML patients and had a significant inhibitory effect on cell proliferation in CML.
[Cell Death & Disease]
7992332
{7992332:CCCCCCCC}
apa
50
1
167485
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/